Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
The Journal of Nutrition
|
April 22, 2011
A chemoprotective fish oil- and pectin-containing diet temporally alters gene expression profiles in exfoliated rat colonocytes throughout oncogenesis
Youngmi Cho, Hyemee Kim, Nancy D Turner, et al.
Clinical and Experimental Medicine
|
February 5, 2021
Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study
Zhi Ao, Yan Li, Jiawei Wei, et al.
Lancet (London, England)
|
September 17, 2013
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Dominique Baeten, Xenofon Baraliakos, Jürgen Braun, et al.
Cancer Communications (London, England)
|
July 17, 2024
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)
Shun Lu, Xiaorong Dong, Hong Jian, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
The Journal of Nutrition
|
April 22, 2011
A chemoprotective fish oil- and pectin-containing diet temporally alters gene expression profiles in exfoliated rat colonocytes throughout oncogenesis
Youngmi Cho, Hyemee Kim, Nancy D Turner, et al.
Clinical and Experimental Medicine
|
February 5, 2021
Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study
Zhi Ao, Yan Li, Jiawei Wei, et al.
Lancet (London, England)
|
September 17, 2013
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Dominique Baeten, Xenofon Baraliakos, Jürgen Braun, et al.
Cancer Communications (London, England)
|
July 17, 2024
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)
Shun Lu, Xiaorong Dong, Hong Jian, et al.
Page
of 5